[A case of intractable myasthenia gravis treated with cyclosporine and high-dose intravenous immunoglobulin]

[Article in Japanese]

Case Reports

[Article in Japanese]

A Sato et al. Nihon Naika Gakkai Zasshi. 1996.

. 1996 Feb 10;85(2):279-81.

No abstract available

Similar articles

A comparison of the effectiveness of intravenous immunoglobulin and plasma exchange as preoperative therapy of myasthenia gravis.
Jensen P, Bril V. Jensen P, et al. J Clin Neuromuscul Dis. 2008 Mar;9(3):352-5. doi: 10.1097/CND.0b013e3181660807. J Clin Neuromuscul Dis. 2008. PMID: 18344718 Clinical Trial.
High-dose intravenous immunoglobulin for the treatment of MuSK antibody-positive seronegative myasthenia gravis.
Takahashi H, Kawaguchi N, Nemoto Y, Hattori T. Takahashi H, et al. J Neurol Sci. 2006 Sep 25;247(2):239-41. doi: 10.1016/j.jns.2006.05.065. Epub 2006 Jul 28. J Neurol Sci. 2006. PMID: 16876198
Low-dose intravenous immunoglobulin therapy in myasthenia gravis: a case report.
Chu CC, Huang CC. Chu CC, et al. Zhonghua Yi Xue Za Zhi (Taipei). 1996 Mar;57(3):232-5. Zhonghua Yi Xue Za Zhi (Taipei). 1996. PMID: 8935232
Safety and tolerability of intravenous immunoglobulins.
Martin TD. Martin TD. Electroencephalogr Clin Neurophysiol Suppl. 1999;50:514-20. Electroencephalogr Clin Neurophysiol Suppl. 1999. PMID: 10689502 Review. No abstract available.
[Myasthenia gravis].
Tanaka K. Tanaka K. Nihon Rinsho. 2004 May;62 Suppl 5:580-5. Nihon Rinsho. 2004. PMID: 15197988 Review. Japanese. No abstract available.